Éva Malpass
TCT 2024: PEERLESS trial finds large-bore mechanical thrombectomy superior for intermediate-risk PE
Findings from the first international randomised controlled trial (RCT) to compare patient outco...
TCT 2024: One-year data from SIRONA trial show similar results for sirolimus versus paclitaxel DCB
Data from the prospective, multicentre, investigator-initiated SIRONA randomised clinical trial ...
EMBLOK enrols 50th patient in TAVI embolic protection trial
EMBLOK has announced that it has enrolled the first 50 patients in a clinical trial to evaluate ...
Cordis announce positive 24-month results from Selution SFA Japan trial
Cordis has announced positive 24-month results from the Selution SFA Japan trial. The prospective, m...
FastWave Medical announces successful 30-day first-in-human data on peripheral IVL technology
FastWave Medical has announced the 30-day results of its first-in-human (FIH) study using the co...
BIOMAG-I two year results confirm safety and efficacy of Biotronik resorbable magnesium scaffold
New two-year follow-up data from the BIOMAG-I first-in-human trial confirms a reliable and predi...
CX 2024: Paclitaxel device restrictions “did cause harm”
“Unfortunately, we are doing worse for our patients today,” were the sobering words of Eric Sece...
Philips launches new motorised mobile C-arm system
Royal Philips has announced the launch of their image-guided therapy mobile C-arm system 9000—Ze...
Philips announces LumiGuide 3D imaging technology availability in Europe and USA
Philips' LumiGuide ‘human GPS’ technology is now available to specialised hospitals in Europe an...
Revascularisation considered over amputation for CLTI in UK, new study states
A new study published in BJS Open has found that revascularisation treatment to restore blood fl...
Late breaking STRIKE-PE data shows improved outcomes for pulmonary embolism patients
Penumbra, a global healthcare company focused on innovative therapies, announced the latest STRI...
Study provides insights from US cohort of FLASH registry for high-risk PE
New research from the FLASH registry shines a light on the effectiveness of large-bore mechanica...
EuroPCR 2023: Bioresorbable scaffolds as effective as drug-eluting metal stents in heart disease patients
First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting...
Machine learning model provides improved cardiac risk predictions compared to “gold-standard” STS scoring
A machine learning-based model which uses electronic health record (EHR) data to predict a cardi...
High-fat diet found to promote atherosclerosis
In a recent study, researchers determined that derivatives of natural emulsifiers such as phosph...
Postmenopausal women with hardened arteries at higher risk of heart attacks than men
Postmenopausal women with clogged arteries are at higher risk of heart attacks than men of simil...
Artificial intelligence predicts cardiac pump performance
A recent study has found deep neural networks (DDNs)—a category of artificial intelligence (AI) ...
Cardiovascular News’ top 10 stories of April 2023
News highlights this April were brought by Podium First data from the BASIL-2 trial presented at...
Talking therapy associated with reduced risk of cardiovascular disease
Effective management of depression through psychological therapy is associated with a lower likeliho...
Increased air pollution associated with a rise in deaths from cardiovascular disease
Deaths from cardiovascular disease are elevated on polluted days and for two days afterwards, accord...
Smart watches could predict higher risk of heart failure and arrhythmia
Wearable devices such as smart watches could be used to detect a higher risk of developing heart fai...
Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis
A prospective observational study had found that, in asymptomatic persons, subclinical obstructi...
Aortix pMCS pump provides “rapid” decongestion for patients with heart failure and renal impairment
Procyrion, a medical device company which aims to improve outcomes for patients with c...
Remote monitoring improves survival in heart failure patients analysis finds
Abbott has today announced new data that found monitoring patients remotely with haemo...
HeartBeam accquires LIVMOR assets
HeartBeam, a cardiac technology company that has developed the three-dimensional (3D)-vector electro...
“Urgent” action needed to improve outcomes in women undergoing coronary artery bypass surgery
Women have been found to have significantly higher risk of operative mortality and postoperative...
Analysis finds clinical trials frequently overlook people with disabilities
Disabilities were underreported in clinical trial data and commonly used as a basis for exclusion fr...
Poor, irregular sleep linked to increased atherosclerosis in adults 45 and above
Sleeping an inconsistent number of hours each night and falling asleep at different times may in...
PCI probability seen to increase at low-volume hospitals for all populations, but has not occurred “evenly” across sociodemographic groups
A retrospective cohort study has found the likelihood of receiving percutaneous coronary interve...
Cardiovascular News’ top 10 most popular stories of January 2023
In the opening month of 2023, Cardiovascular News’ most read stories include sex disparities in clin...
The interventional cardiology trials to watch in 2023
Trials in coronary imaging, transcatheter tricuspid valve interventions, transcatheter aortic va...
BioVentrix receives FDA expanded access program approval for ischemic heart failure treatment system
BioVentrix, a privately held medical device company focused on the development of less invasive ther...
Non-invasive wearable ultrasound sensor shown to provide mobile cardiac imaging
A group of engineers and physicians have created a wearable ultrasonic device that is able to pr...
Improved follow-up care needed for Black patients post-PCI to prevent hospital readmission and death
In a recent study which revealed higher readmission and mortality rates among Black patients fol...
Study finds PET technology more effective to determining need for coronary stents bypass surgery
A new method for determining whether patients with heart disease need coronary stents or bypass ...
Otsuka Medical Devices and ReCor Medical submit pre-market approval of Paradise ultrasound renal denervation system
Otsuka Medical Devices and ReCor Medical, a subsidiary of Otsuka, announce the filing ...
Ninety-day readmission and mortality found to be higher among Black patients following PCI
A retrospective analysis of data collected from the Blue Cross Blue Shield of Michigan Cardiovascula...
